- Current report filing (8-K)
September 15 2010 - 7:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 15, 2010
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-31337
|
|
22-1760285
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Identification
|
of incorporation)
|
|
File Number)
|
|
Number)
|
150 Clove Road, Little Falls, New Jersey
|
|
07424
|
Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(973) 890-7220
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item
7.01 Regulation FD Disclosure
Attached
hereto as Exhibit 99.1 is an investor presentation of Cantel Medical Corp.
(the Company), which may be used in presentations by Company management to
investors, analysts and others from time to time, including a presentation to
be made on September 15, 2010. The
presentation will be posted on the Companys website, www.cantelmedical.com.
The information included in Exhibit 99.1 shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or incorporated by reference in any filing under the Securities Act of 1933, as
amended.
Item
9.01 Financial Statements and Exhibits
(d) Exhibits
99.1
Cantel Medical Corp. Investor Presentation September 15, 2010
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
CANTEL
MEDICAL CORP.
|
|
|
|
|
|
By:
|
/s/
Andrew A. Krakauer
|
|
|
Andrew
A. Krakauer
|
|
|
President
|
|
|
|
Dated:
September 15, 2010
|
|
|
3
Exhibit Index
Exhibit No.
|
|
Exhibit Description
|
|
|
|
99.1
|
|
Cantel
Medical Corp. Investor Presentation September 15, 2010
|
4
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024